Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...
Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...
A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear receptors, ...
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...
Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.
News-Medical.Net on MSN
Opioid receptors caught in motion offering clues for safer painkillers
Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...
Scientists at St. Jude Children’s Research Hospital identified a binding cleft in nuclear receptors offering alternative drug ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback